IPcanna is an established R&D accelerator which is attracting and helping to advance breakthrough science and technologies from around the world.
A "full-spectrum" IP-generation turbine, IPcanna's purpose is to help accelerate medical-cannabis, recreational-cannabis and industrial hemp related invention & innovation by bridging the gaps between Investment, Invention and Monetization.
IPcanna provides a platform for the world's leading inventors, doctors and scientific researchers to learn, communicate and collaborate.
IPcanna experts provide tailored guidance and support via 3 Levels of service:
1. Advisory & Networking – aiding projects in various stages of development to reach the next tier of success and facilitating meaningful global joint ventures and strategic partnerships to increase stakeholder value
2. Advisory, Networking & Financing – development support plus support raising capital and acquiring other needed resources
3. Full Partnership Support – implementing a full development and launch strategy with potential public stock listing
Whether entering the turbine in early- or late-stage development, IPcanna can facilitate the entire IP-generation process from ideation to monetization, including: Hypothesis; Proposal; Funding; R&D; Go-To-Market Strategy; Launch; and long-term IP Management.
Monetization strategies may range from IP licensing to product manufacturing and distribution for wholesale and/or direct consumer markets.
As part of the Dvija Phytoceutical family, IPcanna will share all of the expertise within the global Dvija network, including leading medical-scientific advisory, access to research and clinical trials around the world, proprietary medical strains, genetics & technologies, and an established global trading network.
